FUJIFILM to highlight the latest advances in radiology at ECR 2022 Overture

Düsseldorf, 3rd March 2022 - FUJIFILM Europe GmbH is delighted to be sharing the latest company news and innovative advances in technology at ECR 2022 Overture, an online event taking place on March 2-6.

ECR 2022 Overture is the perfect event for Fujifilm to unveil its vision as the ‘one-stop’ partner of choice for healthcare systems, following the acquisition of the Hitachi Diagnostic Imaging Systems business in 2021. This creates a powerful new force in medical imaging, offering a complete and integrated portfolio of diagnostic products and services, including highly customised and advanced technologies for CT, MRI, X-ray, AI, PACS, endoscopy and ultrasound systems. Masaharu Fukumoto, Senior Vice President and Head of European Medical for FUJIFILM Europe GmbH, will be discussing this vision for the company’s strategic development in Europe – as well as the key projects that will drive the future of radiology – at 3:15 pm CET on the 4th of March.


This event will also feature insights from the very first OASIS Velocity™ customer, Dr. Lawrence Tanenbaum, Chief Technology Officer, Director of Advanced Imaging and Vice President of RadNet Inc. This high-field MRI scanner – the only truly open high-field MRI scanner with SynergyDrive™ – delivers a streamlined workflow and enhanced patient experience, combined with a unique open gantry, integrated radiofrequency (RF) coils and powerful reconstruction technologies for faster whole-body imaging. Dr. Tanenbaum will be talking about the system from both a user and patient perspective at 6:30 pm CET on the 3rd of March.


Visit the Fujifilm ECR Hub and sign up to our newsletter to keep up to date with the latest news.

TM indicates trademarks of FUJIFILM Corporation.



FUJIFILM operates over 50 group companies and branches in Europe and employs approximately 4,500, and is engaged in R&D, manufacturing, sales and service, with FUJIFILM Europe GmbH, located in Düsseldorf, Germany. The company operates as the strategic headquarters for the region. Throughout Europe, FUJIFILM entities serve a range of industries including medical technology, biopharmaceuticals, electronic materials, industrial products, chemicals, graphic systems, optical devices, data storage and all aspects of photography. Over the last 20 years, the company has intensively focused on healthcare – from diagnosis to prevention and treatment. On March 31 2021, FUJIFILM Healthcare Europe, then known as Hitachi Medical Systems Europe, became part of the FUJIFILM group. FUJIFILM Healthcare Europe is a first-choice supplier of open and powerful high-field MRI systems, multi-slice CT systems as well as medical ultrasound devices in all kinds of clinical applications. Together with FUJIFILM Medical Systems Europe, FUJIFILM Healthcare Europe is working side by side, acting as a one stop medical imaging partner that creates new value and contributes to the development of medical care.

For more information about FUJIFILM Europe, visit: https://fujifilm.com


About FUJIFILM Holdings Corporation

FUJIFILM Holdings Corporation, located in Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the fiscal year ended March 31, 2021, the company had global revenues of Euro 16,7 billion, at an exchange rate of 131,6 yen to the Euro. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship.

For more information, please visit: holdings.fujifilm.com